Our Company
By offering a broad and reliable portfolio of GMP‑grade and research‑grade products, IPHASE empowers the development of therapeutic modalities spanning small molecules, monoclonal antibodies, cell and gene therapies (CGT), and oligonucleotide‑based treatments. IPHASE enables researchers to transform scientific ideas into meaningful progress. Our offerings range from recombinant enzymes and subcellular fractions to primary cells, organoids, and biological tissues from both human and animal sources, supporting key research areas including ADME/PK, pharmacodynamics, toxicology, bioanalysis, and pathology. Built on a strong foundation of scientific expertise, technical innovation, and robust in‑house manufacturing, IPHASE delivers the quality, consistency, and scalability required to support discovery, translational research, and preclinical development worldwide.
Extending from this strong product platform, IPHASE also provides product-related CRO services for early drug discovery, including in vitro ADME/PK screening, LC–MS/MS bioanalysis, and pharmacology and efficacy studies.
International Certification
IPHASE commenced by launching its first ADMEs products for early drug screening. Next, we further expanded our product portfolio by robust investment and efforts in developing products for pharmacokinetics, pharmacology, microbiology, immunology, genetics, and clinical medicine based on years of experience in product research, development, and after-sales support. Our products are validated by in-house or international standards (e.g. OECD and ICH) and have gained qualification/patent certificates and wide recognition from peers in the industry.
IPHASE's production center holds full ISO 9001, ISO 45001, and ISO 14001 certifications, accredited by CNAS and IAF. Our entire production and R&D process strictly adheres to international standards, ensuring consistent quality, safety, and environmental responsibility across all our products and services.
 |
 |
 |
Product patent
As of now, we successfully launched more than 3,000 self-developed products: cell culture supplies, cell isolation kit, primary cell, ADME assay kit, genotoxicity test kit, blank biological matrix, and tissue specimen.
In addition, we currently possess more than 600 patented original products. The core competencies of IPHASE lies in the company’s extensive, innovative capability and experience in chemical/biological analysis, cytogenetics, DNA engineering, protein and antibody development, and immunoassays. We currently serve more than 4,000 customers: well-renowned CROs, pharmaceutical companies, scientific research institutions and universities. As a leader in in-vitro biological reagents research, we will always strictly adhere to the corporate motto of “honesty, rigor, and pragmatism” and strive to provide premium quality products that accomplish the IPHASE mission to provide innovative reagents for innovative research!
Company Timeline
